Edwards Lifesciences

Medical Equipment

$ 78 (0.09)%

Share price

$ 48 bn

Market Cap

$ 47 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.03x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Edwards Lifesciences reported gross GHG emissions (Scope 1 + 2 before carbon offsets) for the twelve months ending 31 December 2021 at 46 Kt (-0.34 /-0.7% y-o-y). At the same time, carbon intensity increased to 11 t (+0.9/+9.4% y-o-y).

Edwards Lifesciences reported Scope 3 emissions for the the twelve months ending31 December 2021 at 417

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Carbon offsets	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	46	14	31	417	(1.3)
2020Q4	46	14	32			4,386	11
2019Q4	42	14	28			4,348	9.6

Edwards Lifesciences

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Edwards Lifesciences's carbon footprint

Company environmental metrics